Edition:
India

TapImmune Inc (TPIV.OQ)

TPIV.OQ on NASDAQ Stock Exchange Capital Market

12.33USD
1:30am IST
Change (% chg)

$1.83 (+17.43%)
Prev Close
$10.50
Open
$10.74
Day's High
$12.85
Day's Low
$10.69
Volume
599,271
Avg. Vol
65,738
52-wk High
$12.85
52-wk Low
$2.60

Chart for

About

TapImmune Inc. is an immuno-oncology company. The Company specializes in the development of peptide and gene-based immunotherapeutics and vaccines for the treatment of cancer. The Company is engaged in developing vaccines that target candidate breast cancers, colorectal cancers, ovarian cancers and non-small cell lung cancers.... (more)
No analyst recommendations are available for .

Overall

Beta: --
Market Cap(Mil.): --
Shares Outstanding(Mil.): 10.16
Dividend: --
Yield (%): --

Financials

BRIEF-Tapimmune And Marker Therapeutics Announce Entry Into Merger Agreement

* TAPIMMUNE AND MARKER THERAPEUTICS ANNOUNCE ENTRY INTO MERGER AGREEMENT, CREATING A TRANSFORMATIONAL IMMUNO-ONCOLOGY PLATFORM

15 May 2018

BRIEF-Iroquois Capital Management LLC Reports A 5.5 Pct Stake In TapImmune As Of April 4

* IROQUOIS CAPITAL MANAGEMENT LLC REPORTS A 5.5 PCT STAKE IN TAPIMMUNE AS OF APRIL 4 - SEC FILING

05 Apr 2018

Earnings vs. Estimates

No consensus analysis data available.